A spergillus fumigatus is currently the most important airborne fungal pathogen and the leading cause of invasive aspergillosis (~85% of cases). Despite the introduction of new effective antifungal drugs, the mortality rate of invasive aspergillosis still exceeds 40%. Furthermore, the emergence of drug resistance adds more complications to the treatment process. Hence, new antifungal agents are urgently needed.